Consortium for Tobacco Use Cessation Technical Assistance financed solely by Prevention and Public Health Funds

The Centers for Disease Control and Prevention (CFDA 93.759) funds technical assistance to state tobacco control programs and national partners to translate tobacco cessation science into public health action, with the most recent grant awards issued on September 30, 2013. This program is inactive for business development purposes: no grant awards have been disbursed in the past thirteen years, and no recent grant opportunities are visible in the federal marketplace. The four awards in the portfolio all date to 2013, representing a one-time funding cycle with no subsequent activity.

All four awards funded cooperative agreements structured to provide technical assistance on tobacco cessation policy and state quitline capacity. Cooperative Agreements comprised 100 percent of the assistance-type mix. The Department of Health and Human Services Centers for Disease Control and Prevention was the sole funder, obligating $2.6 million in combined federal dollars across the portfolio. Individual award magnitudes ranged from approximately $450 thousand to $900 thousand.

Representative recent awards included Cooperative Agreement NU58DP004967 ($900 thousand), which supported enhancing state quitline capacity and sustainability through September 2019, and Cooperative Agreement NU58DP004966 ($793 thousand), which provided technical assistance for effective tobacco cessation policies through September 2019. A third cooperative agreement (U58DP004967, $450 thousand) likewise focused on quitline capacity and sustainability through September 2018.

The program's funding is financed solely by Prevention and Public Health Funds. No active grant opportunities are currently posted, and the thirteen-year funding gap since 2013 suggests this assistance listing is no longer an active funding vehicle. Organizations seeking CDC tobacco control funding should direct inquiries to the agency's tobacco control program office to determine whether this line has been reallocated, consolidated, or succeeded by an active opportunity.